Dsip Injection

The inhibitory effect of DSIP injection(Delta Sleep-Inducing Peptide)on stress hormones is by no means limited to a unidimensional passive blockade,

nor is it a blind suppression of all stress-related hormones. Instead, with its core identity as a "regulator of stress homeostasis," it leverages its molecular permeability as a neuropeptide to deeply infiltrate and participate in the synergistic operation of the body's neuro-endocrine stress regulatory network. Its mechanism of action is not singular or rigid but exhibits multidimensional and differentiated regulatory characteristics. By precisely targeting key nodes of stress hormone secretion, DSIP gently mitigates excessive stress responses triggered by external stimuli or internal imbalances, averting physiological damage caused by uncontrolled stress reactions, and ultimately achieving dynamic equilibrium and stability in the body's stress levels.

Products Description

Dsip Peptide

Dsip Injection

Dsip Tablets

Dsip Capsules

​

Dsip COA

Certificate of Analysis
Compound name	Dsip
Grade	Pharmaceutical grade
CAS No.	62568-57-4
Quantity	36g
Packaging standard	PE bag+Al foil bag
Manufacturer	Shaanxi BLOOM TECH Co., Ltd
Lot No.	202601090066
MFG	Jan 9th 2026
EXP	Jan 8th 2029
Structure
Item	Enterprise standard	Analysis result
Appearance	White or almost white powder	Conformed
Water content	≤5.0%	0.54%
Loss on drying	≤1.0%	0.42%
Heavy Metals	Pb≤0.5ppm	N.D.
	As≤0.5ppm	N.D.
	Hg≤0.5ppm	N.D.
	Cd≤0.5ppm	N.D.
Purity (HPLC)	≥99.0%	99.98%
Single impurity	<0.8%	0.52%
Total microbial count	≤750cfu/g	95
E. Coli	≤2MPN/g	N.D.
Salmonella	N.D.	N.D.
Ethanol (by GC)	≤5000ppm	500ppm
Storage	Store in a sealed, dark, and dry place below -20°C

The mildness and specificity of DSIP injection do not exist independently, but rather work synergistically and complement each other, jointly constituting its core advantages. The mildness ensures that the regulation process does not damage the body or disrupt physiological balance, while the specificity ensures precise and efficient regulation without generating irrelevant interference. The combination of the two makes DSIP particularly suitable for scenarios where individuals are under long-term stress and have persistently abnormal elevated stress hormone levels. It can not only alleviate various physiological and emotional damages caused by excessive stress over the long term but also maximize the protection of the body's own endocrine regulation mechanism, truly achieving long-term, safe, and effective stress regulation. This is also its core competitiveness that distinguishes it from other stress regulation substances.

Unlike the generalized effects of conventional regulatory substances, DSIP's targets are directly aimed at adrenocorticotropic hormone (ACTH) and cortisol-the core "stress messengers" in the body's response to external stimuli. Their abnormally high secretion is a key trigger for stress-induced damage such as metabolic disorders, emotional imbalance, and immune attenuation. This medicine achieves precise targeted regulation of these two hormones without interfering with the secretion of other unrelated hormones.

Its core mechanism focuses on the pituitary-adrenal axis (HPA axis), the central hub for the synthesis and release of stress hormones. DSIP can directly penetrate this pathway, inhibiting the secretory activity of ACTH in the pituitary gland, there by cutting its stimulatory transmission to the adrenal cortex. By dismantling the stress hormone production loop at the upstream level, it curbs the synthesis and release of cortisol, achieving source-level regulation of stress hormones.

DSIP's inhibition of stress hormones in the body is not a rigid, one-size-fits-all mechanism, but follows the core logic of "contextual adaptation and dynamic adjustment." It formulates differentiated regulatory strategies based on the characteristics of the body's stress response in different scenarios, precisely matching the physiological demands of acute and chronic stress. This fundamentally breaks the vicious cycle of abnormally elevated stress hormones and prevents the cumulative damage caused by the continuous escalation of the stress response.

01

In acute stress scenarios

Where the body encounters sudden external stimuli (such as sudden fright, short-term high-intensity pressure, accidental trauma, etc.) - DSIP injection leverages its rapid permeability as a neuropeptide to initiate the body's stress response regulation mechanism within a short time. It does not blindly block the normal initiation of the stress response. Instead, by finely tuning the concentration of corticotropin-releasing hormone (CRH) secreted by the hypothalamus, it indirectly suppresses the peak level of ACTH secreted by the pituitary gland. This curbs the sharp surge in cortisol levels over a short period from the intermediate transmission link, thereby alleviating a series of immediate discomfort symptoms caused by acute stress, such as increased heart rate, blood pressure fluctuations, rapid breathing, and emotional agitation. This provides sufficient buffer space for the body to cope with sudden stimuli and avoids physiological dysfunction caused by a sharp rise in stress hormones.

02

In chronic stress scenarios

Where the body is in a prolonged state of continuous pressure (such as long-term work overload, chronic anxiety, persistent sleep deprivation, etc.), leading to the HPA axis being overactivated for an extended period and consistently high basal cortisol secretion - DSIP exerts a sustained regulatory effect. It gradually soothes the overexcited state of the HPA axis and slowly reduces the basal secretion level of cortisol. This fundamentally breaks the vicious cycle where "stress stimuli trigger hormone elevation, and elevated hormones further enhance the body's stress sensitivity." It reduces the long-term erosion of the body's tissues and organs (such as the liver, kidneys, cardiovascular system, and central nervous system) caused by chronic stress, averts irreversible damage like cellular damage, metabolic disorders, and emotional disturbances resulting from prolonged excessive secretion of stress hormones, and helps the body gradually free itself from the challenges of chronic stress.

Load-Reducing Regulation, Guiding the Body from Stress Imbalance to Homeostasis

DSIP's inhibition of ACTH and cortisol is, in essence, a precise reduction of the body's stress load. By lowering the concentrations of these two stress hormones, it effectively mitigates excessive energy consumption during stress, prevents the body from falling into an energy deficit due to prolonged stress, and maintains normal metabolic rhythms.

Concurrently, this inhibitory effect protects the normal activity of immune cells, averting the suppression of the immune system caused by excessive stress hormone secretion. It reduces stress-related declines in immune function while also diminishing the persistent stimulation of the central nervous system by stress hormones. This alleviates negative emotions such as anxiety and irritability induced by stress, guiding the body from a state of dysregulation caused by excessive stress back to physiological homeostasis. 

DSIP's specificity permeates its entire process of action, with the core being "precise positioning, no diffusion, no interference." It acts exclusively on pathways and targets related to stress hormone secretion, effectively avoiding potential physiological risks associated with non-specific regulation. This is detailed in three core dimensions:

First, Specificity of Action Targets: DSIP's targets are strictly limited to the two key stress hormones, adrenocorticotropic hormone (ACTH) and cortisol. It does not involve any other unrelated hormones and does not interfere with the secretion of non-stress hormones such as insulin, thyroid hormones, or sex hormones, achieving precise regulation of the target hormones.

Second, Specificity of Action Pathways: Its core scope of action is focused on the hypothalamic-pituitary-adrenal (HPA) axis, the central hub for the synthesis and release of stress hormones. It only penetrates and intervenes in the relevant regulatory links of this pathway, without diffusing to affect other endocrine systems, such as the thyroid or reproductive endocrine systems, thus avoiding disruption to the body's overall endocrine system.

Third, Specificity of Regulatory Effects: This high degree of specificity allows DSIP injection to preserve the body's intrinsic stress-regulatory capacity while exerting its regulatory effects. When the body encounters stress stimuli within the normal range, it can still initiate its stress response mechanism normally and effectively cope with external challenges. The body does not lose its stress defense capabilities due to DSIP's action, ensuring the safety and rationality of the regulation.

• Does DSIP increase HGH?

Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women.

• How safe is DSIP?

No significant side-effects have so far been reported with DSIP. In some human studies, transient headache, nausea and vertigo have been reported.

• When to inject DSIP?

Repeated administrations indicated a buildup with normalization of sleep structure after four administrations. Repeated injections in the morning - besides increasing daytime activity - still had a strong positive effect on night sleep, but not so two doses daily.

• Does DSIP increase HGH?

Delta sleep-inducing peptide administration does not influence growth hormone and prolactin secretion in normal women.

Hot Tags: dsip injection, China dsip injection manufacturers, suppliers, CJC 1295 Tablets, HCG Oral Tablets, IGF 1 LR3 Spray, MT2 Injection, PT 141 Injection, Sermorelin Acetate Injection